Microchip Technology MCHP is set to report its fourth-quarter fiscal 2025 results on May 8. Microchip expects net sales between $920 million and $1 billion for the third quarter of fiscal 2025.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Microchip Technology stock (NASDAQ:MCHP) a company that manufactures microcontrollers, mixed-signal, analog, and Flash-IP integrated circuits, surged by close to 12% in Friday’s trading and ...

Tánaiste and Minister for Foreign Affairs and Trade Simon Harris has warned the US administration of the negative consequences of imposing tariffs on imported pharmaceuticals and microchips. Mr ...

Maria Azzurra Volpe is a Newsweek Life & Trends reporter based in London, U.K. Her focus is reporting on everyday life topics and trending stories. She has covered Pet Care and Wildlife stories ...

WASHINGTON, May 7 (Reuters) - President Donald Trump said on Wednesday he will soon have an announcement on whether the U.S. will ease microchip export restrictions to some Gulf countries.

Tanaiste Simon Harris has written to US Secretary for Commerce Howard Lutnick (PA) Ireland’s deputy premier has warned the US administration of the negative consequences of imposing tariffs on ...

Microchip Technology is up ~6% in after-hours trading Thursday after releasing fiscal 2025 Q4 results that beat on both lines and initiating FY26 Q1 EPS guidance. The company projects Q1 non-GAAP ...

The Irish deputy premier has written to US Secretary for Commerce Howard Lutnick on two sectors that are key to Ireland’s economy. Tanaiste Simon Harris has written to US Secretary for Commerce ...

Vector Security has provided intelligent security solutions for more than 50 years. Headquartered in Pittsburgh, the company offers a full suite of electronic security services for residential ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their research efforts around the adeno-associated virus (AAV) vectors used ...